Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Goodwill & Intangibles: 2013-2024

Historic Goodwill & Intangibles for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Dec 2024 value amounting to $628.6 million.

  • Amphastar Pharmaceuticals' Goodwill & Intangibles rose 0.38% to $629.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $629.0 million, marking a year-over-year increase of 0.38%. This contributed to the annual value of $628.6 million for FY2024, which is 0.29% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Goodwill & Intangibles stood at $628.6 million for FY2024, which was up 0.29% from $626.8 million recorded in FY2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Goodwill & Intangibles peaked at $628.6 million during FY2024, and registered a low of $43.8 million during FY2022.
  • In the last 3 years, Amphastar Pharmaceuticals' Goodwill & Intangibles had a median value of $626.8 million in 2023 and averaged $433.1 million.
  • In the last 5 years, Amphastar Pharmaceuticals' Goodwill & Intangibles declined by 2.60% in 2022 and then spiked by 1,329.79% in 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Goodwill & Intangibles (Yearly) stood at $45.8 million in 2020, then declined by 1.62% to $45.0 million in 2021, then dropped by 2.60% to $43.8 million in 2022, then surged by 1,329.79% to $626.8 million in 2023, then increased by 0.29% to $628.6 million in 2024.